Acusensus (ASX:ACE) ROE %: -80.94% (As of Dec. 2025)


ASX:ACE Acusensus Ltd ASX:ACE
59 GF Score
Price A$1.19
GF Value A$1.47
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Acusensus ROE %?

Acusensus ASX:ACE -5.20% 59 ROE % is -80.94% as of Dec. 2025. GuruFocus rates ASX:ACE with a GF Score™ of 59/100 and a GF Value™ of A$1.47 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 2,681 Software companies, Acusensus ranks worse than 86.87% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Acusensus's annualized net income for the quarter that ended in Dec. 2025 was A$-41.63 Mil. Acusensus's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was A$51.43 Mil. Therefore, Acusensus's annualized ROE % for the quarter that ended in Dec. 2025 was -80.94%.

The historical rank and industry rank for Acusensus's ROE % or its related term are showing as below:

ASX:ACE' s ROE % Range Over the Past 10 Years
Min: -45.63   Med: -4.24   Max: 0.16
Current: -45.63

During the past 4 years, Acusensus's highest ROE % was 0.16%. The lowest was -45.63%. And the median was -4.24%.

ASX:ACE's ROE % is ranked worse than
86.87% of 2681 companies
in the Software industry
Industry Median: 4.73 vs ASX:ACE: -45.63

Acusensus  (ASX:ACE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-41.626/51.426
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-41.626 / 80.56)*(80.56 / 86.405)*(86.405 / 51.426)
=Net Margin %*Asset Turnover*Equity Multiplier
=-51.67 %*0.9324*1.6802
=ROA %*Equity Multiplier
=-48.18 %*1.6802
=-80.94 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-41.626/51.426
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-41.626 / -41.274) * (-41.274 / -5.8) * (-5.8 / 80.56) * (80.56 / 86.405) * (86.405 / 51.426)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0085 * 7.1162 * -7.2 % * 0.9324 * 1.6802
=-80.94 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Acusensus ROE % Related Terms


Acusensus ROE % Historical Data

* Premium members only.

The historical data trend for Acusensus's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusensus ROE % Chart

Acusensus Annual Data
Trend Jun22 Jun23 Jun24 Jun25
ROE %
0.00 0.16 -4.24 -6.34

Acusensus Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial -1.33 -7.09 -2.44 -8.93 -80.94

ASX:ACE vs MSFT, ORCL, PLTR: ROE % Comparison

For the Software - Infrastructure subindustry, Acusensus's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acusensus ROE % vs Software Industry

For the Software industry and Technology sector, Acusensus's ROE % distribution charts can be found below:

* The bar in red indicates where Acusensus's ROE % falls into.


ASX:ACE
59GF Score
Acusensus Ltd ASX:ACE
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acusensus ROE % Calculation

Acusensus's annualized ROE % for the fiscal year that ended in Jun. 2025 is calculated as

ROE %=Net Income (A: Jun. 2025 )/( (Total Stockholders Equity (A: Jun. 2024 )+Total Stockholders Equity (A: Jun. 2025 ))/ count )
=-2.624/( (35.924+46.79)/ 2 )
=-2.624/41.357
=-6.34 %

Acusensus's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-41.626/( (46.79+56.062)/ 2 )
=-41.626/51.426
=-80.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -80.94% mean?
Acusensus (ASX:ACE) has a ROE % of -80.94% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Acusensus and its competitors. According to the industry distribution chart, Acusensus ranks #2329 out of 2681 companies in the Software industry, placing it in the top 86.9%.
Is Acusensus' ROE % too high?
Acusensus' current ROE % is -80.94%. Based on the distribution chart, Acusensus ranks #2329 out of 2681 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Acusensus has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acusensus' ROE % compare to MSFT and ORCL?
According to the Software industry distribution chart, Acusensus ranks #2329 out of 2681 companies for ROE %. This places Acusensus in the lower half of its industry. The industry median ROE % is 4.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Software company?
The median ROE % among Software companies is 4.73, based on 2,681 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Acusensus and its competitors. For the Software industry, the median ROE % is 4.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acusensus's current ROE % is -80.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.47, compared to a current price of A$1.19 — trading 19.4% below its estimated fair value. The current ROE % is -80.94%. Acusensus' overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current ROE % is -80.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acusensus (ASX:ACE) Overvalued in 2026?

Based on GuruFocus' analysis, Acusensus stock appears to be undervalued. The current stock price of A$1.19 is trading 19.4% below its estimated GF Value™ of A$1.47. GuruFocus considers Acusensus to be Modestly Undervalued.

Key valuation signals for ASX:ACE:

  • ROE %: -80.94%
  • GF Value™: A$1.47 vs. price of A$1.19 (19.4% below fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Acusensus Business Description

Address 31 Queen Street, Level 1, Melbourne, VIC, AUS, 3000
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
59GF Score

Get the complete analysis for ASX:ACE

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.19
Price
A$1.47
GF Value